Take Action at the Cancer Center
Clinical trials are research studies designed to answer scientific questions and discover better ways to prevent, diagnose, or treat various diseases and conditions. A clinical trial is one of the last stages of a long and careful process. Scientists begin by developing and testing new ideas in a laboratory. If a treatment seems promising, the next step may be testing it in animals to learn how it affects the disease in a living being and if it has harmful effects.
Treatments that work in a lab or in animals may not always work well in people. When a potential treatment seems safe enough to try in humans, it proceeds to be studied in a clinical trial. These trials are done with patients to learn whether promising treatments are safe and effective.
The most successful treatments today are based on what we have learned from clinical trials. As a result, people with various diseases are living longer and with a better quality of life.
Quotes
If you are interested in joining a clinical trial, the research team and your provider are your go-to sources, but here are the answers to some of the most common questions:
*Note that we use “treatment” when answering these questions, but the same answers can be used for clinical trials studying how we provide care, such as blood tests or imaging.
What Are Clinical Trials?
Clinical trials are research studies designed to answer scientific questions and discover better ways to prevent, diagnose, or treat various diseases and conditions. A clinical trial is one of the last stages of a long and careful process. Scientists begin by developing and testing new ideas in a laboratory. If a treatment seems promising, the next step may be testing it in animals to learn how it affects the disease in a living being and if it has harmful effects.
Treatments that work in a lab or in animals may not always work well in people. When a potential treatment seems safe enough to try in humans, it proceeds to be studied in a clinical trial. These trials are done with patients to learn whether promising treatments are safe and effective.
The most successful treatments today are based on what we have learned from clinical trials. As a result, people with various diseases are living longer and with a better quality of life.
What Are the Benefits and Risks?
Sometimes patients enroll in a clinical trial to get early access to what could be a promising therapy. However, there are no guarantees that the therapy will work or that they will be assigned to the group of patients who get the therapy. Patients may be assigned to a comparison group instead that receives another approved treatment or placebo (a pill with no medication). The new treatment may also cause additional side effects. That is why a treatment may be offered in a trial where doctors can monitor patients very closely.
How is This Different from Getting Regular Treatment?
When your doctor needs to prescribe a treatment for you, they prescribe an approved treatment that is the standard of care for your disease or condition. If there is a clinical trial available for your condition, it may have two or more different treatments that you could be assigned to. One treatment will always be the standard treatment. The other treatment will usually be the standard treatment plus the new treatment. By the time a potential new treatment is available through a clinical trial, this means that doctors have a reasonable idea that it could be beneficial for patients with your condition now or as the future standard of care.
Being part of a clinical trial means you will never receive anything less than the standard treatment. You will just have the chance to get a potential new treatment in addition.
What About Costs?
The costs of any drugs or care are covered by your insurance or the clinical trial’s sponsor. There can be some costs to you — such as transportation and childcare from any additional doctor’s visits or tests. In many cases, there are ways of helping you with these costs.
Why Be Part of a Clinical Trial?
Participating in clinical trials at UI Health may not only benefit you but also could help future patients through the development of new, safer treatments. To make sure the FDA has a full picture of the risk or benefit of a medical product, patients enrolled in trials should be representative of patients who will likely to use the medical product in the future. Having diverse clinical trials helps the FDA understand how new medical products may help or affect groups of future patients, such as:
- People of color
- Underserved populations
- Older people
- Women
Is It Safe to Be in a Clinical Trial?
We understand you or your loved ones may be nervous about joining a clinical trial. However, we do everything in our power to protect the rights, safety, and welfare of all UI Health patients participating in clinical trials. Institutional Review Boards, independent of the people conducting the trial, carefully review plans for research involving patients before the research begins and at least once a year during the trial.
How Can I Be in a Trial?
Your doctor may already have a trial in mind and may ask you if you would like to participate. You also can ask your healthcare provider to find out if there are any clinical trials that may be right for you. You can look for clinical trials to participate in by visiting the National Library of Medicine’s website at www.clinicaltrials.gov
Diversity in Clinical Trials: How University of Illinois Cancer Center is Fighting Cancer Disparities
From family history to a person’s living environment to a lack of access to healthcare, there are many reasons why disparities exist in cancer care. One of these reasons is the lack of diversity among participants in clinical trials.
Many diseases affect people of different races and ethnicities, which is why clinical trials are more effective if the participants represent all types of patients. However, minority groups are significantly underrepresented among clinical trial participants.
Diversity in Clinical Trials
- Black people make up 13.4% of the US population, but only 5% of all clinical trial participants.
- People of Hispanic or Latino origin represent 18.1% of the US population, but only 1% of all clinical trial participants.
- Less than 5% of breast cancer studies look at race and socioeconomic factors when drawing conclusions from the study’s results.
- Over 96% of prostate cancer clinical trial participants are non-Hispanic white men — despite the fact that 22% of prostate cancer diagnoses are in non-Hispanic Black men.
Sources: The American Journal of Managed Care (2020), JAMA Oncology (2019), Clinical Research Pathways, Oncology Nursing Society
Increasing diversity is essential to improving cancer care for all patients. Having diverse clinical trials helps the FDA understand how new medical products may help or affect groups of future patients, such as:
- People of color
- Underserved populations
- Older people
- Women
At the Cancer Center, our goal is to eliminate disparities in cancer care — and one way we do that is by increasing representation of minority groups in our research. The Cancer Center and UI Health serves a highly diverse population, and many of our clinical trials draw on participation from our patients. This allows us to make a direct impact on our diverse community and reduce disparities in cancer research.
Quotes
To find a clinical trial at University of Illinois Cancer Center currently enrolling patients, please see the Cancer Clinical Trials Clinical Trials listing.
For more information about cancer clinical trials, please see the following resources:
- Food & Drug Administration
- National Institutes of Health
- National Cancer Institute (NCI): Clinical Trials Information for Patients and Caregivers
- The American Cancer Society: Clinical Trials
- Cancer Support Community: Cancer Clinical Trials
Contact Us
To learn more about clinical trials, contact the University of Illinois Cancer Center Clinical Trials Office: